captopril has been researched along with Chronic Lung Injury in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askari, VR; Boskabadi, J; Boskabady, MH; Hosseini, M | 1 |
| Chen, Y; Jeng, MJ; Lin, CH | 1 |
| Huang, W; Jiang, W; Li, Y; Zeng, Z; Zhang, X; Zhou, M | 1 |
| Chen, Y; Du, YQ; Guo, JF; Guo, XR; Li, ZS; Yu, QH | 1 |
| Chen, X; Ji, ZZ; Li, SL; Wu, T; Zhang, XW | 1 |
| Bedi, M; Cohen, EP; Irving, AA; Jacobs, E; Klein, J; Lawton, CA; Moulder, JE; Tomic, R | 1 |
| Fish, BL; Gao, F; Jacobs, ER; Medhora, M; Moulder, JE; Szabo, A | 1 |
| Han, B; He, X; Liu, M; Liu, Z; Ma, T; Mura, M; Wang, S; Xia, S | 1 |
1 trial(s) available for captopril and Chronic Lung Injury
| Article | Year |
|---|---|
Mitigation of late renal and pulmonary injury after hematopoietic stem cell transplantation.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Kidney Failure, Chronic; Lung Injury; Male; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Transplantation Conditioning; Whole-Body Irradiation | 2012 |
7 other study(ies) available for captopril and Chronic Lung Injury
| Article | Year |
|---|---|
Immunomodulatory properties of captopril, an ACE inhibitor, on LPS-induced lung inflammation and fibrosis as well as oxidative stress.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Biomarkers; Captopril; Cytokines; Fibrosis; Immunologic Factors; Lipopolysaccharides; Lung; Lung Injury; Male; Neutrophils; Oxidative Stress; Pneumonia; Rats; Rats, Wistar | 2019 |
Effects of intratracheal captopril on severely meconium-injured piglet lungs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Captopril; Lung; Lung Injury; Male; Meconium Aspiration Syndrome; Swine; Trachea | 2019 |
Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation.
Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Survival; Endothelial Cells; Gene Expression Regulation; Imidazoles; Interleukin-6; Leucine; Lipopolysaccharides; Lung Injury; Male; MAP Kinase Signaling System; Microcirculation; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tumor Necrosis Factor-alpha | 2015 |
Captopril pretreatment protects the lung against severe acute pancreatitis induced injury via inhibiting angiotensin II production and suppressing Rho/ROCK pathway.
Topics: Acute Disease; Amylases; Angiotensin II; Animals; Capillary Permeability; Captopril; Humans; Lung; Lung Injury; Male; Organ Size; Pancreas; Pancreatitis; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2016 |
[Protective effects of captopril against lung injury in rats with severe acute pancreatitis].
Topics: Amylases; Angiotensin II; Animals; Captopril; Disease Models, Animal; Lung; Lung Injury; Male; Pancreatitis; Peroxidase; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2010 |
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dose-Response Relationship, Radiation; Female; Humans; Lung; Lung Injury; Proportional Hazards Models; Radiation Injuries; Radiation Pneumonitis; Rats; Rats, Wistar; Respiration; Tachypnea; Time Factors | 2012 |
Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endothelial Cells; Intercellular Adhesion Molecule-1; Lung; Lung Injury; Male; NF-kappa B; Oleic Acid; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Tissue Plasminogen Activator | 2007 |